loadpatents
Patent applications and USPTO patent grants for AHN; Hyo Min.The latest application filed is for "antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegf".
Patent | Date |
---|---|
Antitumor Immunity Enhancing Composition Containing Adenovirus Simultaneously Expressing Il-12 And Shvegf App 20220233718 - YUN; Chae Ok ;   et al. | 2022-07-28 |
Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor Grant 11,364,272 - Yun , et al. June 21, 2 | 2022-06-21 |
Anticancer Composition Comprising Tumor-specific Oncolytic Adenovirus And Immune Checkpoint Inhibitor App 20190388488 - YUN; Chae Ok ;   et al. | 2019-12-26 |
Anticancer Composition Comprising Recombinant Adenovirus Expressing Degradation Factor For Extracellular Matrix App 20190358277 - YUN; Chae Ok ;   et al. | 2019-11-28 |
Antitumor Immunity Enhancing Composition Containing Adenovirus Simultaneously Expressing Il-12 And Shvegf App 20180369417 - YUN; Chae Ok ;   et al. | 2018-12-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.